| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Theseus Pharmaceuticals, Inc. | Chief Technical Officer | Stock Option (right to buy) | 130,000 | 18 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322007499-dalgarno-david-2022-02-18 | Theseus Pharmaceuticals, Inc. | 18 Feb 2022 | 1 | $0 | 4 | Chief Technical Officer | 23 Feb 2022, 19:00 |
| /report/000089924321039495-dalgarno-david-2021-10-06 | Theseus Pharmaceuticals, Inc. | 06 Oct 2021 | 0 | $0 | 3 | Chief Technical Officer | 06 Oct 2021, 19:00 |